Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin

Diabetes Technology and Therapeutics - Tập 16 Số 3 - Trang 137-144 - 2014
Sunder Mudaliar1, Robert R. Henry1, Guenther Boden2, Steven R. Smith3, Alexandros-Georgios Chalamandaris4, Dominique Duchesne5, Nayyar Iqbal5, James F. List5
1Center for Metabolic Research, VA San Diego Healthcare System and University of California, San Diego, San Diego, California
2School of Medicine, Temple University, Philadelphia, Pennsylvania
3Florida Hospital, Orlando, Florida
4Bristol-Myers Squibb, Braine-l’Alleud, Belgium
5Bristol-Myers Squibb, Princeton, New Jersey

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/j.mcna.2004.04.013

10.1016/S1262-3636(08)73394-9

Boden G, 1996, Am J Physiol, 270, E251

10.1111/j.1464-5491.2009.02847.x

10.1515/JPEM.2003.16.1.5

10.1172/JCI113157

10.1172/JCI112981

Zinker B, 2011, Diabetes, 60, A283

10.1016/S0140-6736(10)60407-2

10.2337/diacare.25.9.1597

DeBodo RC, 1963, Recent Prog Horm Res, 19, 445

10.1172/JCI110398

10.1089/152091503322641060

10.2337/diab.36.8.914

10.1016/S0950-351X(87)80011-3

10.1172/JCI109464

10.2337/dc11-0606

10.1161/CIRCULATIONAHA.106.171016

Thông tin
Thông tin xuất bản

Diabetes Technology and Therapeutics

Tập 16 Số 3

137-144

Thông tin tác giả